{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:36:32Z","timestamp":1781195792875,"version":"3.54.1"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"name":"Plan Nacional de I+D+I"},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI12\/00240"],"award-info":[{"award-number":["FIS PI12\/00240"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Development Regional Fund","award":["CB06\/02\/0053"],"award-info":[{"award-number":["CB06\/02\/0053"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Antimicrob. Chemother."],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1093\/jac\/dkv333","type":"journal-article","created":{"date-parts":[[2016,1,12]],"date-time":"2016-01-12T20:04:15Z","timestamp":1452629055000},"page":"362-366","source":"Crossref","is-referenced-by-count":19,"title":["Deep analysis of HIV-1 natural variability across HIV-1 variants at residues associated with integrase inhibitor (INI) resistance in INI-naive individuals"],"prefix":"10.1093","volume":"71","author":[{"given":"Teresa","family":"Ll\u00e1cer Delicado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Torrecilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1frica","family":"Holgu\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,11,5]]},"reference":[{"key":"2016012123582312000_71.2.362.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.01.007"},{"key":"2016012123582312000_71.2.362.2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004171"},{"key":"2016012123582312000_71.2.362.3","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku144"},{"key":"2016012123582312000_71.2.362.4","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2011.0266"},{"key":"2016012123582312000_71.2.362.5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/135965350701200411","article-title":"Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance","volume":"12","author":"Lataillade","year":"2007","journal-title":"Antivir Ther"},{"key":"2016012123582312000_71.2.362.6","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks474"},{"key":"2016012123582312000_71.2.362.7","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01535-07"},{"key":"2016012123582312000_71.2.362.8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-368"},{"key":"2016012123582312000_71.2.362.9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms14035013"},{"key":"2016012123582312000_71.2.362.10","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2012.0058"},{"key":"2016012123582312000_71.2.362.11","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01791-12"},{"key":"2016012123582312000_71.2.362.12","doi-asserted-by":"publisher","DOI":"10.1310\/hct1401-10"},{"key":"2016012123582312000_71.2.362.13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092747"},{"key":"2016012123582312000_71.2.362.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.04.013"},{"key":"2016012123582312000_71.2.362.15","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr389"},{"key":"2016012123582312000_71.2.362.16","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.17.4.19749"},{"key":"2016012123582312000_71.2.362.17","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/jac\/dku474","article-title":"G118R and F121Y mutations identified in patients failing raltegravir treatment confer dolutegravir resistance","volume":"70","author":"Munir","year":"2014","journal-title":"J Antimicrob Chemotherapy"},{"key":"2016012123582312000_71.2.362.18","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03353-14"},{"key":"2016012123582312000_71.2.362.19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/135965350901400108","article-title":"Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes","volume":"14","author":"Ma\u00efga","year":"2009","journal-title":"Antivir Ther"},{"key":"2016012123582312000_71.2.362.20","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2652-12-11"},{"key":"2016012123582312000_71.2.362.21","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-11-7"},{"key":"2016012123582312000_71.2.362.22","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv243"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/71\/2\/362\/6991959\/dkv333.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T13:12:51Z","timestamp":1654089171000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkv333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,5]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,1,12]]},"published-print":{"date-parts":[[2016,2]]}},"alternative-id":["10.1093\/jac\/dkv333"],"URL":"https:\/\/doi.org\/10.1093\/jac\/dkv333","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,5]]}}}